Antag Therapeutics ApS
38402056ActivePioneering novel GIP receptor antagonist therapies for treating chronic obesity.
Översikt
- 7
- Anställda
- Okänt
- Omsättning
- 2017
- Grundat
Nyckelbeslutsfattare
Jens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Beskrivning
Antag Therapeutics is a clinical-stage biopharmaceutical company based in Copenhagen, Denmark, dedicated to redefining the treatment of obesity and metabolic disorders. The company focuses on pioneering a novel class of therapies through GIP receptor antagonism to address the limitations of current...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- APS
- Momsnummer
- DK38402056
Beslutsfattare
3 kontakter i FunnelfeedrJens Juul Holst
Founder and Professor
Philip Just Larsen
Chief Executive Officer
Mette Rosenkilde
Founder and Professor
Liknande företag
20 liknande företag i FunnelfeedrAlveus Therapeutics ApS
12 anställdaClinical-stage biotech developing next-generation therapies for obesity and metabolic diseases.
ZEALAND PHARMA A/S
520 anställdaInnovative biotechnology company developing peptide-based medicines for metabolic health.
ASCENDIS PHARMA A/S
629 anställdaGlobal biopharmaceutical company developing innovative therapies using proprietary TransCon technology.
Pephexia Therapeutics ApS
5 anställdaDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
ZEALAND PHARMA A/S
0 anställdaDeveloping peptide medicines for metabolic health challenges globally.
Utforska mer
Frågor om Antag Therapeutics ApS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo